These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 6854944)

  • 21. Medical management of antimicrobial-associated diarrhea and colitis.
    Gotz VP; Rand KH
    Pharmacotherapy; 1982; 2(2):100-9. PubMed ID: 6765392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental studies of antibiotic associated colitis.
    Bartlett JG
    Scand J Infect Dis Suppl; 1980; (Suppl 22):11-5. PubMed ID: 6937944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Clostridium difficile-associated intestinal disease.
    Rolfe RD
    Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
    Wang R; Suo L; Chen HX; Song LJ; Shen YY; Luo YP
    Int J Infect Dis; 2018 Feb; 67():86-91. PubMed ID: 28736259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Clostridium difficile diarrhoea in Harare, Zimbabwe.
    Simango C; Uladi S
    Trans R Soc Trop Med Hyg; 2014 Jun; 108(6):354-7. PubMed ID: 24664819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibilities of Clostridium difficile.
    Shuttleworth R; Taylor M; Jones DM
    J Clin Pathol; 1980 Oct; 33(10):1002-5. PubMed ID: 7430354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile carriage in healthy pregnant women in China.
    Ye GY; Li N; Chen YB; Lv T; Shen P; Gu SL; Fang YH; Li LJ
    Anaerobe; 2016 Feb; 37():54-7. PubMed ID: 26633756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.
    Aronsson B; Möllby R; Nord CE
    Med Microbiol Immunol; 1981; 170(1):27-35. PubMed ID: 7300801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium sordellii in diarrhoeal stools, its medical significance.
    Butra ND; Vichivanives P
    J Med Assoc Thai; 1991 May; 74(5):264-70. PubMed ID: 1783874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.
    Chow AW; Cheng N; Bartlett KH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):842-4. PubMed ID: 4083868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.
    Thorpe CM; McDermott LA; Tran MK; Chang J; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Snydman DR
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
    Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.
    Kim KH; Fekety R; Batts DH; Brown D; Cudmore M; Silva J; Waters D
    J Infect Dis; 1981 Jan; 143(1):42-50. PubMed ID: 7217711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diarrhoea and pseudomembranous colitis after gastrointestinal operations. A prospective study.
    Keighley MR; Burdon DW; Alexander-Williams J; Shinagawa N; Arabi Y; Thompson H; Youngs D; Bentley S; George RH
    Lancet; 1978 Dec; 2(8101):1165-7. PubMed ID: 82138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
    McConnie R; Kastl A
    Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
    George WL; Rolfe RD; Harding GK; Klein R; Putnam CW; Finegold SM
    Infection; 1982; 10(4):205-8. PubMed ID: 7129642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea.
    Niyogi SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):156-8. PubMed ID: 1430970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.